Amcor
AMCR NYSE Paper & Plastic Packaging Products & Materials Financials FY2017βFY2026
Amcor's revenue rose 56.6% to $23.5 billion in fiscal 2026. Its operating margin was 8.1%, up from 6.7% a year earlier. Free cash flow was $1.2 billion, up 51.7%. It paid out $1.2 billion in dividends and buybacks, 97% of free cash flow. The diluted share count rose 45.6%.
About these figures. Amcor's filings from fiscal 2023 tag its inventories only in two parts with no total, so inventory and the quick ratio are left blank in every year, to keep the years comparable. Share counts and per-share figures for earlier years are restated for a stock split (1-for-5), so every year is on today's share basis.
What Amcor does
No business description yet.
- Legal name
- AMCOR PLC
- Fiscal year ends
- June 30, 2026
- Latest annual report
- β
- Accession Β· CIK
- 0001748790-26-000022
0001748790
Revenue and margins
Amcor had $23.5B of revenue in fiscal 2026, up 56.6% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew β0.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2026, 5.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Amcor returned $1.2B to shareholders in fiscal 2026, 97% of free cash flow. The diluted share count rose 45.6%.
Value Amcor yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$12.9B and divides by 463.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 19.4x Β· peers 32.1x Β· sector 20.6x.
Balance sheet
Cash, debt and the ratios that show how comfortably Amcor can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $775M | $689M | $588M | $827M | $1.1B |
| Debt incl. finance leases | $6.5B | $6.7B | $6.7B | $14.1B | $14.0B |
| Net debt / EBITDA | 3.1x | 2.9x | 3.4x | 7.7x | 3.8x |
| Debt / equity | 1.6x | 1.7x | 1.7x | 1.2x | 1.2x |
| Interest coverage | 7.8x | 5.2x | 3.5x | 2.6x | 2.8x |
| Current ratio | 1.2x | 1.2x | 1.2x | 1.2x | 1.3x |
| Total assets | $17.4B | $17.0B | $16.5B | $37.1B | $37.1B |
| Total liabilities | $13.3B | $12.9B | $12.6B | $25.3B | $25.3B |
| Shareholders' equity | $4.1B | $4.0B | $3.9B | $11.7B | $11.8B |
| Net debt (β = net cash) | $5.7B | $6.1B | $6.1B | $13.3B | $12.9B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$2.8M
5 insiders
Sold, 12 months
$0.1M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | Stephen R. SchergerExecutive VP, Finance & CFO | Bought | 121,065 | $8.32 | $1.0M | Form 4 |
| Dec 3, 2025 | Jill A RahmanDirector | Sold | 4,148 | $8.44 | $0.0M | Form 4 |
| Dec 3, 2025 | Susan K CarterDirector | Sold | 6,058 | $8.44 | $0.1M | Form 4 |
| Nov 24, 2025 | Jill A RahmanDirector | Sold | 6,596 | $8.48 | $0.1M | Form 4 |
| Nov 12, 2025 | Nicholas T. LongDirector | Bought | 10,000 | $8.54 | $0.1M | Form 4 |
| Nov 10, 2025 | Ian WilsonExecutive Vice President | Bought | 79,000 | $8.35 | $0.7M | Form 4 |
| Nov 10, 2025 | James T Glerum Jr.Director | Bought | 59,945 | $8.34 | $0.5M | Form 4 |
| Nov 10, 2025 | Peter KoniecznyChief Executive Officer | Bought | 60,000 | $8.41 | $0.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | β3.5% | β3.3% | β2.8% |
| Altman Z'' | 1.28 | 0.97 | 1.21 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Amcor AMCR | $21.4B | 56.6% | 8.1% | 5.2% | 6.6% | β | 6 | |
| International Paper IP | $17.6B | 49.3% | β | β0.7% | β12.3% | β | 4 | Compare β |
| Smurfit Westrock SW | $22.0B | 47.7% | 5.5% | 3.9% | 4.1% | 44.1x | 5 | Compare β |
| Crown CCK | $12.9B | 4.8% | 12.6% | 9.0% | 13.7% | 16.9x | 7 | Compare β |
| Packaging Corporation of America PKG | $22.0B | 7.2% | 12.3% | 8.1% | 11.8% | 32.1x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $9.1B | $9.3B | $9.5B | $12.5B | $12.9B | $14.5B | $14.7B | $13.6B | $15.0B | $23.5B |
| Gross profit | $1.9B | $1.9B | $1.8B | $2.5B | $2.7B | $2.8B | $2.7B | $2.7B | $2.8B | $4.7B |
| Research and development | $69.1M | $72.7M | $64.0M | $97.0M | $100M | $96.0M | $101M | $106M | $120M | $170M |
| Operating income | $916M | $994M | $792M | $994M | $1.3B | $1.2B | $1.5B | $1.2B | $1.0B | $1.9B |
| Interest expense | $191M | $210M | $208M | $207M | $153M | $159M | $290M | $348M | $396M | $676M |
| Pretax income | $716M | $723M | $604M | $825M | $1.2B | $1.1B | $1.3B | $907M | $650M | $1.3B |
| Income tax | $149M | $119M | $172M | $187M | $261M | $300M | $193M | $163M | $135M | $181M |
| Net income | $564M | $575M | $430M | $612M | $939M | $805M | $1.0B | $730M | $511M | $1.1B |
| Diluted EPS | $2.40 | $2.47 | $1.81 | $1.91 | $3.01 | $2.65 | $3.52 | $2.52 | $1.60 | $2.38 |
| Diluted shares | 0.23B | 0.23B | 0.24B | 0.32B | 0.31B | 0.30B | 0.30B | 0.29B | 0.32B | 0.46B |
| Cash flow | ||||||||||
| Cash from operations | $909M | $871M | $776M | $1.4B | $1.5B | $1.5B | $1.3B | $1.3B | $1.4B | $2.2B |
| Capital expenditure | $379M | $365M | $332M | $400M | $468M | $527M | $526M | $492M | $580M | $922M |
| Free cash flow | $530M | $506M | $444M | $984M | $993M | $999M | $735M | $829M | $810M | $1.2B |
| Depreciation and amortization | $374M | $357M | $453M | $652M | $574M | $625M | $586M | $595M | $722M | $1.5B |
| Stock-based compensation | $26.5M | $21.0M | $19.0M | $34.0M | $58.0M | $63.0M | $54.0M | $32.0M | $74.0M | $83.0M |
| Acquisitions | $336M | $0.0M | $41.9M | $0.0M | $0.0M | $0.0M | $121M | $20.0M | $1.7B | $17.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $537M | $351M | $601M | $432M | $30.0M | $0.0M | $1.0M |
| Dividends paid | $489M | $527M | $680M | $761M | $742M | $732M | $723M | $722M | $845M | $1.2B |
| Dividends and buybacks | $489M | $527M | $680M | $1.3B | $1.1B | $1.3B | $1.2B | $752M | $845M | $1.2B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $562M | $621M | $602M | $743M | $850M | $775M | $689M | $588M | $827M | $1.1B |
| Total debt | β | $4.8B | $6.1B | $6.2B | $6.3B | $6.5B | $6.7B | $6.7B | $14.1B | $14.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $33.0M | $32.0M | $62.0M | $50.0M | $43.0M | $56.0M | $44.0M |
| Current assets | β | $3.6B | $5.2B | $4.5B | $5.3B | $5.9B | $5.3B | $5.0B | $8.4B | $9.3B |
| Current liabilities | β | $5.1B | $4.5B | $4.0B | $4.3B | $5.1B | $4.5B | $4.3B | $7.0B | $7.4B |
| Property and equipment, net | β | $2.7B | $4.0B | $3.6B | $3.8B | $3.6B | $3.8B | $3.8B | $8.2B | $7.4B |
| Total assets | β | $9.1B | $17.2B | $16.4B | $17.2B | $17.4B | $17.0B | $16.5B | $37.1B | $37.1B |
| Total liabilities | β | $8.4B | $11.5B | $11.8B | $12.4B | $13.3B | $12.9B | $12.6B | $25.3B | $25.3B |
| Shareholders' equity | $588M | $627M | $5.6B | $4.6B | $4.8B | $4.1B | $4.0B | $3.9B | $11.7B | $11.8B |
| Margins | ||||||||||
| Gross margin | 21.0% | 19.9% | 19.0% | 20.3% | 21.2% | 19.4% | 18.5% | 19.9% | 18.9% | 20.0% |
| Operating margin | 10.1% | 10.7% | 8.4% | 8.0% | 10.3% | 8.5% | 10.3% | 8.9% | 6.7% | 8.1% |
| EBITDA margin | 14.2% | 14.5% | 13.2% | 13.2% | 14.7% | 12.8% | 14.3% | 13.3% | 11.5% | 14.4% |
| Net margin | 6.2% | 6.2% | 4.6% | 4.9% | 7.3% | 5.5% | 7.1% | 5.4% | 3.4% | 4.7% |
| FCF margin | 5.8% | 5.4% | 4.7% | 7.9% | 7.7% | 6.9% | 5.0% | 6.1% | 5.4% | 5.2% |
| Returns | ||||||||||
| Return on capital | β | β | 7.0% | 7.2% | 10.1% | 9.0% | 12.8% | 9.9% | 4.6% | 6.6% |
| Return on capital employed | β | β | 9.5% | 7.9% | 10.4% | 9.9% | 12.1% | 9.8% | 4.8% | 6.4% |
| Return on equity | β | β | 13.8% | 12.0% | 20.0% | 18.2% | 25.9% | 18.5% | 6.6% | 9.4% |
| Return on assets | β | β | 3.3% | 3.6% | 5.6% | 4.7% | 6.1% | 4.4% | 1.9% | 3.0% |
| Growth | ||||||||||
| Revenue growth | β | 2.4% | 1.5% | 31.8% | 3.2% | 13.1% | 1.0% | β7.2% | 10.0% | 56.6% |
| Net income growth | β | 2.0% | β25.2% | 42.3% | 53.4% | β14.3% | 30.2% | β30.3% | β30.0% | 116.4% |
| EPS growth | β | 2.9% | β26.5% | 5.2% | 57.6% | β12.1% | 33.3% | β28.5% | β36.5% | 48.8% |
| FCF growth | β | β4.4% | β12.4% | 121.7% | 0.9% | 0.6% | β26.4% | 12.8% | β2.3% | 51.7% |
| Share count change | β | β0.2% | 1.9% | 35.3% | β2.9% | β2.6% | β2.6% | β2.4% | 10.6% | 45.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 3.1x | 4.4x | 3.3x | 2.9x | 3.1x | 2.9x | 3.4x | 7.7x | 3.8x |
| Debt / equity | β | 7.7x | 1.1x | 1.4x | 1.3x | 1.6x | 1.7x | 1.7x | 1.2x | 1.2x |
| Interest coverage | 4.8x | 4.7x | 3.8x | 4.8x | 8.6x | 7.8x | 5.2x | 3.5x | 2.6x | 2.8x |
| Current ratio | β | 0.7x | 1.2x | 1.1x | 1.2x | 1.2x | 1.2x | 1.2x | 1.2x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 4.2% | 3.9% | 3.5% | 3.2% | 3.6% | 3.6% | 3.6% | 3.6% | 3.9% | 3.9% |
| Stock comp / revenue | 0.3% | 0.2% | 0.2% | 0.3% | 0.5% | 0.4% | 0.4% | 0.2% | 0.5% | 0.4% |
| Payouts / FCF | 92.4% | 104.0% | 153.2% | 131.9% | 110.1% | 133.4% | 157.1% | 90.7% | 104.3% | 97.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | β | β | 5.0 | 8.0 | 5.0 | 6.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | β | β0.0 | 1.2 | 1.1 | 1.4 | 1.2 | 1.4 | 1.3 | 1.0 | 1.2 |
| Accruals ratio | β | β | β2.6% | β4.6% | β3.1% | β4.2% | β1.2% | β3.5% | β3.3% | β2.8% |
Source: SEC EDGAR XBRL filings (CIK 0001748790). Data updated October 10, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.